Philip Mease, MD: The Role of JAK Inhibitors in Psoriatic Arthritis
November 13th 2019Philip Mease, MD, Director of Rheumatology Research at the Swedish Rheumatology Research Group, discusses why he believes some rheumatologists are skeptical of JAK inhibitors and where they fit in current treatment algorithms.
Survival for Severe Scleroderma Significantly Improved with Stem Cell Transplantation
Patients with severe scleroderma who were treated with hematopoietic stem cell transplantation showed significant improvement in long-term outcomes such as survival and functional status.
Baricitinib Provides Greater Pain Relief to Patients with Refractory Rheumatoid Arthritis
October 24th 2018Patients with rheumatoid arthritis who had inadequate response to previous biologic disease-modifying antirheumatic drugs found greater pain relief when taking 2 mg or 4 mg of baricitinib compared with placebo.